产品详情
简单介绍：
Anti-C6orf72抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-C6orf72抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-C6orf72
Cat. Number:
Anti-C6orf72抗体KL-15253R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset
Anti-C6orf72抗体intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf72 gene product has been provisionally designated C6orf72 pending further characterization.
Also known as:
C6orf72; GINM1_HUMAN;
Anti-C6orf72抗体dJ12G14.2; Uncharacterized protein C6orf72.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C6orf72.
●
Predicted Molecular Weight: 35kDa.
Storage:
Shipped at 4℃, Store at -20℃
Anti-C6orf72抗体(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other Anti-C6orf72抗体applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other Anti-C6orf72抗体applications.
Optimal working dilutions must be determined by the end user.
kl575Mu02 二级**组织趋化因子(SLC)多克隆抗体 Polyclonal Antibody to Secondary Lymphoid Tissue Chemokine (SLC)
kl578Mu02 IgG-Fc片段受体Ⅰ(FcγRⅠ)多克隆抗体 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin G (FcgRI)
kl581Mu01 IgE-Fc受体Ⅰ(FcεRⅠ)多克隆抗体 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin E (FceRI)
kl581Mu02 IgE-Fc受体Ⅰ(FcεRⅠ)多克隆抗体 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin E (FceRI)
kl582Mu02 IgE-Fc片段受体Ⅱ(FcεRⅡ)多克隆抗体 Polyclonal Antibody to Receptor II For The Fc Region Of Immunoglobulin E (FceRII)
kl589Mu02 干扰素调节因子3(IRF3)多克隆抗体 Polyclonal Antibody to Interferon Regulatory Factor 3 (IRF3)
kl592Mu02 胱天蛋白酶1(CASP1)多克隆抗体 Polyclonal Antibody to Caskle 1 (CASP1)
kl593Mu02 **细胞抗原75(LY75)多克隆抗体 Polyclonal Antibody to Lymphocyte Antigen 75 (LY75)
kl598Mu01 干扰素调节因子5(IRF5)多克隆抗体 Polyclonal Antibody to Interferon Regulatory Factor 5 (IRF5)
kl598Mu02 干扰素调节因子5(IRF5)多克隆抗体 Polyclonal Antibody to Interferon Regulatory Factor 5 (IRF5)
kl601Mu02 B-**细胞趋化因子1(BLC1)多克隆抗体 Polyclonal Antibody to B-Lymphocyte Chemoattractant 1 (BLC1)
kl603Ra01 生长调节致癌基因β(GROβ)多克隆抗体 Polyclonal Antibody to Growth Regulated Oncogene Beta (GROb)
kl604Ra01 生长调节致癌基因γ(GROγ)多克隆抗体 Polyclonal Antibody to Growth Regulated Oncogene Gamma (GROg)
kl607Mu02 胸肾表达趋化因子(BRAK)多克隆抗体 Polyclonal Antibody to Breast And Kidney Expressed Chemokine (BRAK)
kl607Ra01 胸肾表达趋化因子(BRAK)多克隆抗体 Polyclonal Antibody to Breast And Kidney Expressed Chemokine (BRAK)
kl613Mu02 凝血因子ⅩⅢB肽(F13B)多克隆抗体 Polyclonal Antibody to Coagulation Factor XIII B Polypeptide (F13B)
kl617Hu01 GDP解离抑制因子1(GDI1)多克隆抗体 Polyclonal Antibody to GDP Dissociation Inhibitor 1 (GDI1)
kl626Mu02 白介素10受体α(IL10Rα)多克隆抗体 Polyclonal Antibody to Interleukin 10 Receptor Alpha (IL10Ra)
